Pharmalot - STAT

Pharmalot By Ed Silverman

Pfizer looks to widen access to Covid-19 vaccine in Africa, but advocates say it doesn’t go far enough

Pharmalot By Ed Silverman

States reach $26 billion deal with three wholesalers and J&J to end opioid lawsuits

Pharmalot By Ed Silverman

Pharmalittle: Pfizer cuts deal for Covid-19 shot to be partially made in South Africa; wholesalers to pay $1.1b to NY to settle opioid suit

Paper cup pills nonadherent noncompliant

Pharmalot By Ed Silverman

FDA plans to study whether pharma reps at conference exhibit booths are telling the truth

Pharmalot By Ed Silverman

Three pharma wholesalers reach a $1.1 billion deal with New York over the opioid crisis

Pharmalot By Ed Silverman

As a key hearing nears, Justice Department calls Purdue’s bankruptcy plan unconstitutional

Pharmalot By Ed Silverman

Pharmalittle: Wholesalers near deal over opioid litigation; pharma gives $67,400 to Peters for trying to torpedo drug pricing bill

Pharmalot By Ed Silverman

Advocates urge Biden to name patent office director that could transform drug pricing

Pharmalot By Elizabeth Cooney

Pharmalittle: ICER medical experts find no benefit for Aduhelm; FDA panel votes down Fibrogen’s anemia drug

Pharmalot By Ed Silverman

Up and down the ladder: The latest comings and goings

Pharmalot By Ed Silverman

Pharmalittle: FDA head admits possible missteps in Alzheimer’s drug approval; two major health systems won’t administer Biogen drug

Pharmalot By Ed Silverman

Pharmalittle: Half-dozen big insurers won’t cover new Alzheimer’s drug; Medicaid could spend up to $2.2 billion on the Biogen drug

Pharmalot By Ed Silverman

Biogen’s new Alzheimer’s drug could cost Medicaid up to $2.2 billion a year

Pharmalot By Ed Silverman

Pharmalittle: Medicare starts coverage review for Biogen Alzheimer’s drug; U.S. needs more data before deciding on Covid booster shot

Pharmalot By Ed Silverman

Biden’s executive order would pause a Trump rule forbidding march-in rights to lower drug costs

Pharmalot By Ed Silverman

Dozens of generic makers and pharmacies won’t face lawsuits over Zantac and cancer risks

Pharmalot By Ed Silverman

Pharmalittle: U.S. officials and Pfizer to meet over Covid-19 booster shots; FDA full approval for vaccines may not be a game changer

Pharmalot By Ed Silverman

Up and down the ladder: The latest comings and goings

Pharmalot By Damian Garde

Pharmalittle: Even FDA officials balked at the broad Aduhelm label; CDC and FDA are dubious about Covid booster shots

Pharmalot By Ed Silverman

FDA extends shelf life for glaucoma drug discontinued by Pfizer, but patients remain concerned

Pharmalot By Ed Silverman

House Democrats say pharma stock buybacks and dividends exceed R&D spending

Pharmalot By Ed Silverman

Former Genentech scientist convicted of stealing trade secrets given to former JHL Biotech execs

Pharmalot By Ed Silverman

Purdue reaches deal with 15 states in a significant step toward bankruptcy plan approval

Pharmalot By Ed Silverman

Pharmalittle: In rare move, FDA revises label for Biogen Alzheimer’s drug; former compounding exec gets added jail time

Pharmalot By Ed Silverman

Most Read

Expert panel votes unanimously that Biogen Alzheimer’s drug doesn’t offer patient benefits

FDA scolds Amgen over a misleading ad that could deter use of biosimilar versions of its drug

Too close for comfort: FDA shouldn’t loosen conflict rules for its expert panels

Dutch authorities fine drug maker $23 million for ‘excessive’ pricing of a rare disease drug

U.K. issues record fine to drug makers for price gouging and collusion schemes

Insulin makers and pharmacy benefit managers must face racketeering claims in a lawsuit

Pharmalittle: Pfizer seeks full FDA approval for its Covid-19 vaccine; CT attorney general calls some Sacklers ‘entitled thugs’

Amid Purdue bankruptcy talks, Connecticut attorney general accuses some Sacklers of intimidation

All Coverage

Pfizer looks to widen access to Covid-19 vaccine in Africa, but advocates say it doesn’t go far enough

States reach $26 billion deal with three wholesalers and J&J to end opioid lawsuits

Pharmalittle: Pfizer cuts deal for Covid-19 shot to be partially made in South Africa; wholesalers to pay $1.1b to NY to settle opioid suit

FDA plans to study whether pharma reps at conference exhibit booths are telling the truth

Three pharma wholesalers reach a $1.1 billion deal with New York over the opioid crisis

As a key hearing nears, Justice Department calls Purdue’s bankruptcy plan unconstitutional

Pharmalittle: Wholesalers near deal over opioid litigation; pharma gives $67,400 to Peters for trying to torpedo drug pricing bill

Advocates urge Biden to name patent office director that could transform drug pricing

Pharmalittle: ICER medical experts find no benefit for Aduhelm; FDA panel votes down Fibrogen’s anemia drug

Up and down the ladder: The latest comings and goings

Pharmalittle: FDA head admits possible missteps in Alzheimer’s drug approval; two major health systems won’t administer Biogen drug

Pharmalittle: Half-dozen big insurers won’t cover new Alzheimer’s drug; Medicaid could spend up to $2.2 billion on the Biogen drug

Biogen’s new Alzheimer’s drug could cost Medicaid up to $2.2 billion a year

Pharmalittle: Medicare starts coverage review for Biogen Alzheimer’s drug; U.S. needs more data before deciding on Covid booster shot

Biden’s executive order would pause a Trump rule forbidding march-in rights to lower drug costs

Dozens of generic makers and pharmacies won’t face lawsuits over Zantac and cancer risks

Pharmalittle: U.S. officials and Pfizer to meet over Covid-19 booster shots; FDA full approval for vaccines may not be a game changer

Up and down the ladder: The latest comings and goings

Pharmalittle: Even FDA officials balked at the broad Aduhelm label; CDC and FDA are dubious about Covid booster shots

FDA extends shelf life for glaucoma drug discontinued by Pfizer, but patients remain concerned

House Democrats say pharma stock buybacks and dividends exceed R&D spending

Former Genentech scientist convicted of stealing trade secrets given to former JHL Biotech execs

Purdue reaches deal with 15 states in a significant step toward bankruptcy plan approval

Pharmalittle: In rare move, FDA revises label for Biogen Alzheimer’s drug; former compounding exec gets added jail time

Pharmalittle: Another lawmaker calls for probe of FDA approval of Alzheimer’s drug; Roche urged to lower price of Covid-19 therapy